Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Acute methotrexate-induced encephalopathy--causal relation to homozygous allelic state for MTR c.2756A>G (D919G)?

Linnebank M, Malessa S, Moskau S, Semmler A, Pels H, Klockgether T, Schlegel U.

J Chemother. 2007 Aug;19(4):455-7.

PMID:
17855192
2.

Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate.

Becker A, Vezmar S, Linnebank M, Pels H, Bode U, Schlegel U, Jaehde U.

Int J Clin Pharmacol Ther. 2007 Sep;45(9):504-15.

PMID:
17907593
3.

Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.

Linnebank M, Moskau S, Jürgens A, Simon M, Semmler A, Orlopp K, Glasmacher A, Bangard C, Vogt-Schaden M, Urbach H, Schmidt-Wolf IG, Pels H, Schlegel U.

Neuro Oncol. 2009 Feb;11(1):2-8. doi: 10.1215/15228517-2008-082. Epub 2008 Sep 19.

4.

Magnetization transfer imaging provides no evidence of demyelination in methotrexate-induced encephalopathy.

Miese FR, Schuster FR, Pierstorff K, Karenfort M, Laws HJ, Borkhardt A, Saleh A.

AJNR Am J Neuroradiol. 2011 Jun-Jul;32(6):E110-2. doi: 10.3174/ajnr.A2181. Epub 2010 Jul 22.

5.

Plasma homocysteine, methionine and S-adenosylhomocysteine levels following high-dose methotrexate treatment in pediatric patients with acute lymphoblastic leukemia or Burkitt lymphoma: association with hepatotoxicity.

Kubota M, Nakata R, Adachi S, Watanabe K, Heike T, Takeshita Y, Shima M.

Leuk Lymphoma. 2014 Jul;55(7):1591-5. doi: 10.3109/10428194.2013.850684. Epub 2013 Nov 14.

PMID:
24090503
6.

Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.

Bhojwani D, Sabin ND, Pei D, Yang JJ, Khan RB, Panetta JC, Krull KR, Inaba H, Rubnitz JE, Metzger ML, Howard SC, Ribeiro RC, Cheng C, Reddick WE, Jeha S, Sandlund JT, Evans WE, Pui CH, Relling MV.

J Clin Oncol. 2014 Mar 20;32(9):949-59. doi: 10.1200/JCO.2013.53.0808. Epub 2014 Feb 18.

7.

Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.

Vagace JM, Caceres-Marzal C, Jimenez M, Casado MS, de Murillo SG, Gervasini G.

Am J Hematol. 2011 Jan;86(1):98-101. doi: 10.1002/ajh.21897.

8.

Biochemical and clinical aspects of methotrexate neurotoxicity.

Vezmar S, Becker A, Bode U, Jaehde U.

Chemotherapy. 2003 May;49(1-2):92-104. Review.

PMID:
12714818
9.

The methionine synthase polymorphism c.2756A>G alters susceptibility to glioblastoma multiforme.

Semmler A, Simon M, Moskau S, Linnebank M.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2314-6.

10.

Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer.

Inaba H, Khan RB, Laningham FH, Crews KR, Pui CH, Daw NC.

Ann Oncol. 2008 Jan;19(1):178-84. Epub 2007 Oct 17.

11.

[Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings].

Garcia-Puig M, Fons-Estupina MC, Rives-Sola S, Berrueco-Moreno R, Cruz-Martinez O, Campistol J.

Rev Neurol. 2012 Jun 16;54(12):712-8. Spanish.

12.

Effects of intraventricular methotrexate on folate, adenosine, and homocysteine metabolism in cerebrospinal fluid.

Quinn CT, Griener JC, Bottiglieri T, Arning E, Winick NJ.

J Pediatr Hematol Oncol. 2004 Jun;26(6):386-8.

PMID:
15167354
13.

Polymorphisms of genes controlling homocysteine levels and IQ score following the treatment for childhood ALL.

Krajinovic M, Robaey P, Chiasson S, Lemieux-Blanchard E, Rouillard M, Primeau M, Bournissen FG, Moghrabi A.

Pharmacogenomics. 2005 Apr;6(3):293-302.

PMID:
16013960
14.

Association between the 2756A> G variant in the gene encoding methionine synthase and myocardial infarction in Tunisian patients.

Jemaa R, Achouri A, Kallel A, Ben Ali S, Mourali S, Feki M, Elasmi M, Taieb SH, Sanhaji H, Omar S, Mechmeche R, Kaabachi N.

Clin Chem Lab Med. 2008;46(10):1364-8. doi: 10.1515/CCLM.2008.306.

PMID:
18844488
15.

Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolites.

Ackermann R, Semmler A, Maurer GD, Hattingen E, Fornoff F, Steinbach JP, Linnebank M.

J Neurooncol. 2010 May;97(3):425-7. doi: 10.1007/s11060-009-0028-9. Epub 2009 Oct 11.

PMID:
19821069
16.

Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism.

Müller J, Kralovánszky J, Adleff V, Pap E, Németh K, Komlósi V, Kovács G.

Anticancer Res. 2008 Sep-Oct;28(5B):3051-4.

17.

Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.

Küker W, Bader P, Herrlinger U, Heckl S, Nägele T.

J Neurooncol. 2005 May;73(1):47-9.

PMID:
15933817
18.

The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma.

Linnebank M, Schmidt S, Kölsch H, Linnebank A, Heun R, Schmidt-Wolf IG, Glasmacher A, Fliessbach K, Klockgether T, Schlegel U, Pels H.

Br J Cancer. 2004 May 17;90(10):1969-71.

19.
20.

Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction.

Chen J, Stampfer MJ, Ma J, Selhub J, Malinow MR, Hennekens CH, Hunter DJ.

Atherosclerosis. 2001 Feb 15;154(3):667-72.

PMID:
11257268
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk